Riskpilot← Back to searchSign inGet full accessCryocenter Scandinavia AB
ABActiveOrg 5566297759Drottninggatan 13Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20021-4 employees
Revenue 2025
SEK 27K
-99% vs 2024
EBITDA margin
-1395.0%
-172% vs 2024
Equity ratio
37.0%
Financial strength
Net profit 2025
SEK -316
-132% vs 2024
| Revenue | SEK 27K | -99% |
| EBITDA | SEK -373K | -172% |
| Net profit | SEK -316 | -132% |
| Total assets | SEK 358K | -70% |
| Equity | SEK 132K | -1% |
| Employees | — | — |
Legal name
Cryocenter Scandinavia AB
Org number
5566297759
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27 juni 2002
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva handel och uthyrning av medicinteknisk och högteknologiska, dermatologiska och kosmetiska behandlingssystem.
Address
Drottninggatan 13
Phone
+46703163730
Email
mats@cryocenter.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 944 | 3 363 | 3 997 | 4 670 | 27 |
| Staff expenses | — | — | — | — | −21 |
| EBITDA | 1 164 | −403 | 566 | 519 | −373 |
| Depreciation & amort. | −16 | −8 | −8 | −8 | −3 |
| EBIT | 1 148 | −411 | 558 | 511 | −376 |
| Net financials | −1 | 39 | — | −45 | −19 |
| Profit before tax | 727 | 9 | 8 | 47 | 4 |
| Tax | −0 | −4 | −2 | −46 | −5 |
| Net profit | 727 | 5 | 6 | 1 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 082 | 1 212 | 2 889 | 1 186 | 358 |
| Equity | 1 577 | 126 | 132 | 133 | 132 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 505 | 1 086 | 2 757 | 1 053 | 226 |
| Total debt | 505 | 1 086 | 2 757 | 1 053 | 226 |
EBITDA margin
-1395.0%
This company
15.8%
Market median
-8929% vs market
20212025
Equity ratio
37.0%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
20212025
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20212025
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20212025
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
RM | Audit | 2022 – 2024 |
RV Chief Auditor | Chief Auditor | 2024 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SKINLITE AB
Cryocenter Scandinavia AB Board members of Cryocenter Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Arne Weberg | Chief Executive Officer | 0 companies |
| Rickard Mats Yngve Julin | Audit | 0 companies |
| Robin Victor Mattias Pilebäck | Chief Auditor | 0 companies |
| Eva Marie Weberg | Deputy Board Member | 0 companies |